ClinicalTrials.gg
Not yet recruitingNCT07937358PAPE-KBUpdated Nov 16, 2026

PAPE STRATEGIES AND PERFORMANCE IN MALE KICKBOXERS

An interventional study of Plyometric Jump (PLY) and Heavy Squat (HS) in Post-Activation Performance Enhancement (PAPE), sponsored by Inonu University. Not yet recruiting. Open to male participants aged 18 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Inonu University · Not applicable, Interventional, and Other

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 24 Years
Sex
Male
01

Study summary

This study aims to investigate the acute effects of different post-activation performance enhancement (PAPE) strategies on agility and explosive performance in male kickboxers. Twenty trained male kickboxers will participate in a single-group, repeated-measures experimental study involving four conditions: plyometric jumps (PLY), heavy squats (HS), isometric squats (ISO), and control (CON). The effects of these conditions will be evaluated using countermovement jump (CMJ) height, relative peak power, and the Illinois Agility Test. All four conditions will be performed in a randomized order, with a minimum washout period of 72 hours between sessions.

Read the detailed description

This study was designed as a single-group, repeated-measures experimental study to investigate the acute effects of different conditioning activities on agility and explosive performance in male kickboxers.

Twenty trained male kickboxers aged 18-24 years will participate in the study. All participants will have at least three years of licensed sporting experience and an active training and competition background.

Following anthropometric assessments and a familiarization session with the Illinois Agility Test, participants will complete four experimental conditions in a randomized order: (1) Plyometric Jump (PLY), (2) Heavy Squat (HS), (3) Isometric Squat (ISO), and (4) Control (CON). A minimum washout period of 72 hours will be provided between sessions. To minimize circadian variation, all sessions for each participant will be conducted at approximately the same time of day.

Each experimental session will begin with a standardized five-minute warm-up consisting of three minutes of light jogging and two minutes of dynamic lower-limb mobilization exercises.

In the PLY condition, participants will perform three sets of five drop jumps from a platform height of 30-40 cm, emphasizing maximal explosive effort and short ground contact time.

In the HS condition, participants will perform one set of three back squats at 90% of their individually determined one-repetition maximum (1RM), with a knee flexion angle of approximately 90 degrees.

In the ISO condition, participants will perform three sets of 30-second wall-supported isometric squats, maintaining approximately 90 degrees of knee flexion, with one minute of passive recovery between sets.

In the CON condition, participants will complete the same standardized warm-up but will not perform any additional conditioning activity. A six-minute passive recovery period will follow the warm-up.

Following each conditioning activity, participants will complete a six-minute passive recovery period before performing two maximal countermovement jump (CMJ) trials. The highest jump height will be used for analysis. Relative peak power will also be recorded using the My Jump Lab application.

After a three-minute passive recovery period, participants will perform the Illinois Agility Test once under each condition. Completion time will be recorded using a dual-beam photocell timing system.

All sessions will be conducted under standardized indoor conditions. Participants will be instructed to avoid intense lower-limb exercise during the 24 hours before each session, caffeine consumption during the preceding 12 hours, and alcohol consumption during the preceding 48 hours.

The study will compare CMJ height, relative peak power, and Illinois Agility Test performance across the four experimental conditions to determine the acute effects of different PAPE strategies.

02

Conditions studied

  • Post-Activation Performance Enhancement (PAPE)
03

In context

Lead sponsor

Inonu University is the lead sponsor of 398 studies on the registry; 98 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 24 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male kickboxers aged 18-24 years.

At least three years of licensed sporting experience.

Previous success in international competitions.

Actively participating in training and competitions.

Willingness to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Individuals who do not meet the specified inclusion criteria.

Individuals unable to complete the experimental testing procedures.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • No intervention
    Control

    Participants will complete the standardized five-minute warm-up but will not perform any additional conditioning activity. This will be followed by six minutes of passive recovery.

  • Experimental
    Plyometric Jump (PLY)

    Participants will perform three sets of five drop jumps from a platform height of 30-40 cm, emphasizing maximal explosive effort and short ground contact time.

    Behavioral: Plyometric Jump (PLY)

  • Experimental
    Heavy Squat (HS)

    Participants will perform one set of three back squats using a load corresponding to 90% of their individually determined one-repetition maximum (1RM), with a knee flexion angle of approximately 90 degrees.

    Behavioral: Heavy Squat (HS)

  • Experimental
    Isometric Squat (ISO)

    Participants will perform three sets of 30-second wall-supported isometric squats, maintaining approximately 90 degrees of knee flexion, with one-minute passive recovery intervals between sets.

    Behavioral: Isometric Squat (ISO)

Interventions

  • BehavioralPlyometric Jump (PLY)

    Participants will perform three sets of five drop jumps from a platform height of 30-40 cm. Each jump will be performed with maximal explosive effort, emphasizing a rapid transition from landing to take-off and minimizing ground contact time.

  • BehavioralHeavy Squat (HS)

    Participants will perform one set of three back squats using a load corresponding to 90% of their individually determined one-repetition maximum (1RM). Squats will be performed to a knee flexion angle of approximately 90 degrees.

  • BehavioralIsometric Squat (ISO)

    Participants will perform three sets of 30-second wall-supported isometric squats, maintaining a knee flexion angle of approximately 90 degrees, with one-minute passive recovery intervals between sets.

06

What researchers measure

Primary outcomes

  1. Illinois Agility Test Performance

    Agility performance will be assessed using the Illinois Agility Test. Participants will complete the standardized 10 × 5 m course as quickly as possible. Completion time will be recorded in seconds using a dual-beam photocell timing system with a measurement precision of 0.01 seconds. Lower completion times indicate better agility performance.

    Time frame: Immediately after the 6-minute passive recovery period following the assigned conditioning activity.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2026
First posted
Nov 16, 2026
StartEst.
Nov 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937358
Lead sponsor
Inonu University
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Halil UÇAR (Research Assistant, Inonu University) — Principal investigator
First posted
Nov 16, 2026
Start date
Nov 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion